12.000
+0,00%
2026-10-19
Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +24.5% | +21.9% | 3 / 3 | +36.3% | -1.16 pp | -0.11 pp | +12.3% | 1.60 | 5.53 | 242 | +36,3% | 2,7 | +24,5% | 5.53 | 7.76 | −28,7% |
| Pts | 4 | 0 | 12 | 12 | 4 | 4 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 12.000 (close price on 2026-10-19)EPS (TTM): 2.168
Financial charts
1.Revenue & growth
VND bn242Q2/26
1.Revenue & growth
VND bn242Q2/26
2.Profit & growth
VND bn2,75Q2/26
3.Profit mix (Penman)
VND bn11,5Q2/26
4.Margins & cost structure
%8.8%Q2/26
5.Returns & cash cycle
% · days8.2%Q2/26
6.Earnings quality & cash
VND bn-5,93Q2/26
7.Asset structure
VND bn331Q2/26
8.Funding & debt health
VND bn · times331Q2/26
9.Revenue backlog
VND bn36,9Q2/26
10.Valuation
times · %5,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %654Q2/26
Adjusted EPS growth, latest quarter
24.5%
Average adjusted EPS growth, 3 quarters
21.9%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26